ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 751109 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 751109; 2) Community: the network communities that were significantly associated with the response to NSC 751109; 3) Molecule: the relationships between components within communities and NSC 751109; 4) MDR: the compounds that were significantly associated with the NSC 751109.

NSC Compound Enrichment Correlation
NSC 627371 2,1,3-Benzoselanadiazole, nitro-6-(trifluoromethyl)- 0.0404100698195781 0.21943939
NSC 641052 Platinum, dichloro[(phenylmethyl)methylsulfinyl]- 1-quinolinyl-, (SP-4-1) 0.0404100698195781 0.17460492
NSC 658420 Null 0.0404100698195781 0.18961808
NSC 671891 Null 0.0404100698195781 0.29108547
NSC 106969 CENTAUREIDIN 0.0407060322613564 0.24445447
NSC 278619 L-Arabinose, 2-amino-4-[(2-amino-1-oxopropyl)amino]-2,4-dideoxy-, monohydrochloride 0.0407060322613564 -0.23357764
NSC 282159 EN 589 0.0407060322613564 0.33724522
NSC 302991 Camptothecin Derivative 0.0407060322613564 0.17111503
NSC 366220 Null 0.0407060322613564 0.28359136
NSC 605607 Null 0.0407060322613564 0.23274898
Total:42  Current:32    [First] [Prev] [Next] [Last]